An update on tremors

Current Opinion in Neurology

Volumn 25, Issue 4, 2012, Pages 475-482

  Zeuner, Kirsten E ^a   Deuschl, Günther ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Classification; Genetics; Neurodegeneration; Treatment; Tremor

Indexed keywords

ADRENALIN; AMIODARONE; BOTULINUM TOXIN; CARISBAMATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CLONAZEPAM; CYCLOSPORIN A; ETIRACETAM; GABAPENTIN; HALOPERIDOL; HARKOSERIDE; ISOETARINE; ITRACONAZOLE; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; ORCIPRENALINE; PHENOBARBITAL; PLACEBO; PREGABALIN; PRIMIDONE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; TERBUTALINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; ZONISAMIDE;

ANXIETY; ATAXIA; BRADYCARDIA; CEREBELLUM; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONFUSION; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE INCREASE; ERECTILE DYSFUNCTION; ESSENTIAL TREMOR; FATIGUE; HEADACHE; HEREDITY; HOLMES TREMOR; HUMAN; LABORATORY TEST; MALAISE; NAUSEA; NERVOUSNESS; ORTHOSTATIC TREMOR; PALATAL TREMOR; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY WRITING TREMOR; REVIEW; SEDATION; SIDE EFFECT; TREATMENT RESPONSE; TREMOR; URINARY TRACT INFECTION;

HUMANS; NEUROIMAGING; TREMOR;

EID: 84863711638     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283550c7e     Document Type: Review

References (99)

1. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010; 25:534-541.
2. Benito-Leon J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 2009; 80:423-425.
3. Adler CH, Shill HA, Beach TG. Essential tremor and Parkinson's disease: lack of a link. Mov Disord 2011; 26:372-377.
4. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord 2011; 26:391-398.
5. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13:2-23. (Pubitemid 28517753)
6. Quinn NP, Schneider SA, Schwingenschuh P, Bhatia KP. Tremor: some controversial aspects. Mov Disord 2011; 26:18-23.
7. Louis ED, Dogu O. Isolated head tremor: part of the clinical spectrum of essential tremor? Data from population-based and clinic-based case samples. Mov Disord 2009; 24:2281-2285.
8. Hedera P, Phibbs FT, Fang JY, et al. Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor. BMC Neurol 2010; 10:66-72.
9. Teive HA. Essential tremor: phenotypes. Parkinsonism Relat Disord 2012; 18 (Suppl 1):S140-S142.
10. Whaley NR, Putzke JD, Baba Y, et al. Essential tremor: phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007; 13:333-339. (Pubitemid 47212788)
11. Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a populationbased study. Lancet Neurol 2005; 4:815-820. (Pubitemid 41619436)
12. Deuschl G, Elble R. Essential tremor-neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord 2009; 24:2033-2041.
13. Jasinska-Myga B, Wider C. Genetics of essential tremor. Parkinsonism Relat Disord 2012; 18 (Suppl 1):S138-S139.
14. Tan EK, Teo YY, Prakash KM, et al. LINGO1 variant increases risk of familial essential tremor. Neurology 2009; 73:1161-1162.
15. Clark LN, Park N, Kisselev S, et al. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet 2010; 18:838-843.
16. Vilarino-Guell C, Wider C, Ross OA, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010; 11:401-408.
17. Wu YW, Prakash KM, Rong TY, et al. Lingo2 variants associated with essential tremor and Parkinson's disease. Hum Genet 2011; 129:611-615.
18. Bourassa CV, Riviere JB, Dion PA, et al. LINGO1 variants in the French-Canadian population. PLoS One 2011; 6:e16254.
19. Lorenzo-Betancor O, Garcia-Martin E, Cervantes S, et al. Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. Eur J Neurol 2011; 18:1085-1089.
20. Zuo X, Jiang H, Guo JF, et al. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population. Neurosci Lett 2010; 481:69-72.
21. Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009; 41:277-279.
22. Tan EK. LINGO1 and essential tremor: linking the shakes. Linking LINGO1 to essential tremor. Eur J Hum Genet 2010; 18:739-740.
23. Findley LJ, Koller WC. Essential tremor: a review. Neurology 1987; 37:1194-1197. (Pubitemid 17137271)
24. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 2004; 62:932-936. (Pubitemid 38435781)
25. Louis ED, Faust PL, Vonsattel JP, et al. Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains. Mov Disord 2009; 24:1600-1605.
26. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007; 130:3297-3307. (Pubitemid 350209079)
27. Erickson-Davis CR, Faust PL, Vonsattel JP, et al. 'Hairy baskets' associated with degenerative Purkinje cell changes in essential tremor. J Neuropathol Exp Neurol 2011; 69:262-271.
28. Rajput AH, Robinson CA, Rajput ML, Rajput A. Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. Parkinsonism Relat Disord 2011; 17:16-21.
29. Rajput AH, Robinson CA, Rajput ML, Rajput A. Specificity of Purkinje cell loss in essential tremor [abstract]. Neurology 2010; 74:A348.
30. Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008; 70:1452-1455. (Pubitemid 351521939)
31. Paris-Robidas S, Brochu E, Sintes M, et al. Defective dentate nucleus GABA receptors in essential tremor. Brain 2012; 135:105-116.
32. Shill HA, Adler CH, Beach TG, et al. Brain biochemistry in autopsied patients with essential tremor. Mov Disord 2012; 27:113-117.
33. Deuschl G. Locus coeruleus dysfunction: a feature of essential or senile tremor? Mov Disord 2012; 27:1-2.
34. Pagan FL, Butman JA, Dambrosia JM, Hallett M. Evaluation of essential tremor with multivoxel magnetic resonance spectroscopy. Neurology 2003; 60: 1344-1347. (Pubitemid 36460992)
35. Louis ED, Shungu DC, Chan S, et al. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002; 333:17-20. (Pubitemid 35223592)
36. Daniels C, Peller M, Wolff S, et al. Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor. Neurology 2006; 67:1452-1456. (Pubitemid 44632071)
37. Benito-Leon J, Alvarez-Linera J, Hernandez-Tamames JA, et al. Brain structural changes in essential tremor: voxel-based morphometry at 3-Tesla. J Neurol Sci 2009; 287:138-142.
38. Quattrone A, Cerasa A, Messina D, et al. Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. AJNR Am J Neuroradiol 2008; 29:1692-1697.
39. Martinelli P, Rizzo G, Manners D, et al. Diffusion-weighted imaging study of patients with essential tremor. Mov Disord 2007; 22:1182-1185. (Pubitemid 47067233)
40. Shin DH, Han BS, Kim HS, Lee PH. Diffusion tensor imaging in patients with essential tremor. AJNR Am J Neuroradiol 2008; 29:151-153.
41. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 2010; 74:988-994.
42. Klein JC, Lorenz B, Kang JS, et al. Diffusion tensor imaging of white matter involvement in essential tremor. Hum Brain Mapp 2011; 32:896-904.
43. Cerasa A, Passamonti L, Novellino F, et al. Fronto-parietal overactivation in patients with essential tremor during Stroop task. Neuroreport 2010; 21:148-151.
44. Louis ED, Benito-Leon J, Vega-Quiroga S, Bermejo-Pareja F. Faster rate of cognitive decline in essential tremor cases than controls: a prospective study. Eur J Neurol 2010; 17:1291-1297.
45. Benito-Leon J, Louis ED, Bermejo-Pareja F. Elderly-onset essential tremor is associated with dementia. Neurology 2006; 66:1500-1505. (Pubitemid 43958543)
46. Troster AI, Woods SP, Fields JA, et al. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol 2002; 9:143-151. (Pubitemid 35013929)
47. Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression and antidepressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol 2007; 14:1138-1146. (Pubitemid 47459747)
48. Louis ED, Benito-Leon J, Bermejo-Pareja F. Philadelphia Geriatric Morale Scale in essential tremor: a population-based study in three Spanish communities. Mov Disord 2008; 23:1435-1440.
49. Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurology 2011; 10:148-161.
50. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011; 77:1752-1755.
51. Elble RJ, Pullman SL, Matsumoto JY, et al. Tremor amplitude is logarithmically related to 4-and 5-point tremor rating scales. Brain 2006; 129:2660-2666. (Pubitemid 44522099)
52. Louis ED, Rios E, Henchcliffe C. How are we doing with the treatment of essential tremor (ET)? Persistence of patients with ET on medication: data from 528 patients in three settings. Eur J Neurol 2010; 17:882-884.
53. Gironell A, Pagonabarraga J, Pascual-Sedano B, Kulisevsky J. Lacosamide, another therapeutic failure in essential tremor: an open-label trial. Mov Disord 2011; 26:183-184.
54. Elble RJ, Biondi DM, Ascher S, et al. Carisbamate in essential tremor: brief report of a proof of concept study. Mov Disord 2010; 25:634-638.
55. Bermejo PE. Zonisamide in patients with essential tremor and Parkinson's disease. Mov Disord 2007; 22:2137-2138.
56. Bermejo PE, Ruiz-Huete C, Dorado R, Anciones B. Zonisamide in refractory essential tremor. Rev Neurol 2008; 46:139-142. (Pubitemid 351397737)
57. Handforth A, Martin FC, Kang GA, Vanek Z. Zonisamide for essential tremor: an evaluator-blinded study. Mov Disord 2009; 24:437-440.
58. Ondo WG. Zonisamide for essential tremor. Clin Neuropharmacol 2007; 30:345-349. (Pubitemid 350307313)
59. Zesiewicz TA, Ward CL, Hauser RA, et al. A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor. Mov Disord 2007; 22:279-282. (Pubitemid 46374780)
60. Ferrara JM, Kenney C, Davidson AL, et al. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci 2009; 285:195-197.
61. Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006; 66:672-677. (Pubitemid 43739820)
62. Flora ED, Perera CL, Cameron AL, Maddern GJ. Deep brain stimulation for essential tremor: a systematic review. Mov Disord 2010; 25:1550-1559.
63. Fasano A, Herzog J, Raethjen J, et al. Gait ataxia in essential tremor is differentially modulated by thalamic stimulation. Brain 2011; 133:3635-3648.
64. Herzog J, Hamel W, Wenzelburger R, et al. Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor. Brain 2007; 130:1608-1625. (Pubitemid 47355924)
65. Fytagoridis A, Blomstedt P. Complications and side effects of deep brain stimulation in the posterior subthalamic area. Stereotact Funct Neurosurg 2010; 88:88-93.
66. Blomstedt P, Sandvik U, Hariz MI, et al. Influence of age, gender and severity of tremor on outcome after thalamic and subthalamic DBS for essential tremor. Parkinsonism Relat Disord 2011; 17:617-620.
67. O'Connor RJ, Kini MU. Nonpharmacological and nonsurgical interventions for tremor: a systematic review. Parkinsonism Relat Disord 2011; 17:509-515.
68. Manto M, Rocon E, Pons J, et al. Evaluation of a wearable orthosis and an associated algorithm for tremor suppression. Physiol Meas 2007; 28:415-425. (Pubitemid 46540444)
69. Rocon E, Manto M, Pons J, et al. Mechanical suppression of essential tremor. Cerebellum 2007; 6:73-78. (Pubitemid 46410659)
70. Bilodeau M, Keen DA, Sweeney PJ, et al. Strength training can improve steadiness in persons with essential tremor. Muscle Nerve 2000; 23:771-778. (Pubitemid 30256609)
71. Cooper C, Evidente VG, Hentz JG, et al. The effect of temperature on hand function in patients with tremor. J Hand Ther 2000; 13:276-288.
72. Feys P, Helsen W, Liu X, et al. Effects of peripheral cooling on intention tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76:373-379. (Pubitemid 40299128)
73. Gillard DM, Cameron T, Prochazka A, Gauthier MJ. Tremor suppression using functional electrical stimulation: a comparison between digital and analog controllers. IEEE Trans Rehabil Eng 1999; 7:385-388. (Pubitemid 29444318)
74. Javidan M, Elek J, Prochazka A. Attenuation of pathological tremors by functional electrical stimulation II: clinical evaluation. Ann Biomed Eng 1992; 20:225-236.
75. Espay AJ, Hung SW, Sanger TD, et al. A writing device improves writing in primary writing tremor. Neurology 2005; 64:1648-1650. (Pubitemid 40617713)
76. Bain PG. Parkinsonism & related disorders. Tremor. Parkinsonism Relat Disord 2007; 13 (Suppl 3):S369-S374.
77. Elble R, Deuschl G. Milestones in tremor research. Mov Disord 2011; 26:1096-1105.
78. Ferlazzo E, Morgante F, Rizzo V, et al. Successful treatment of Holmes tremor by levetiracetam. Mov Disord 2008; 23:2101-2103.
79. Striano P, Elefante A, Coppola A, et al. Dramatic response to levetiracetam in postischaemic Holmes' tremor. BMJ Case Rep 2009; 2009:438-439. (Pubitemid 46591278)
80. Striano P, Elefante A, Coppola A, et al. Dramatic response to levetiracetam in postischaemic Holmes' tremor. J Neurol Neurosurg Psychiatry 2007; 78:438-439. (Pubitemid 46591278)
81. Sanborn MR, Danish SF, Ranalli NJ, et al. Thalamic deep brain stimulation for midbrain tremor secondary to cystic degeneration of the brainstem. Stereotact Funct Neurosurg 2009; 87:128-133.
82. Acar G, Acar F, Bir LS, et al. Vim stimulation in Holmes' tremor secondary to subarachnoid hemorrhage. Neurol Res 2010; 32:992-994.
83. Brittain JS, Jenkinson N, Holland P, et al. Development of Holmes' tremor following hemi-cerebellar infarction. Mov Disord 2011; 26:1957-1959.
84. Block F, Dafotakis M. Drug-induced tremor. Fortschr Neurol Psychiatr 2011; 79:570-575.
85. Lestner JM, Denning DW. Tremor: a newly described adverse event with longterm itraconazole therapy. J Neurol Neurosurg Psychiatry 2011; 81:327-329.
86. Leu-Semenescu S, Roze E, Vidailhet M, et al. Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord 2007; 22:2063-2069.
87. Baker M, Fisher K, Lai M, et al. Slow orthostatic tremor in multiple sclerosis. Mov Disord 2009; 24:1550-1553.
88. Jones L, Bain PG. Orthostatic tremor. Pract Neurol 2011; 11:240-243.
89. Hellriegel H, Raethjen J, Deuschl G, Volkmann J. Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study. Mov Disord 2011; 26:2431-2434.
90. Hai C, Yu-ping W, Hua W, Ying S. Advances in primary writing tremor. Parkinsonism Relat Disord 2011; 16:561-565.
91. Bain PG, Findley LJ, Britton TC, et al. Primary writing tremor. Brain 1995; 118 (Pt 6):1461-1472. (Pubitemid 26011916)
92. Rana AQ, Vaid HM. A review of primary writing tremor. Int J Neurosci 2011; 122:114-118.
93. Espay AJ, Chen R. Primary writing tremor and writer's cramp: distinct phenomenology, diverging pathophysiology. Clin Neurophysiol 2011; 122: 5-6.
94. Meunier S, Bleton JP, Mazevet D, et al. TENS is harmful in primary writing tremor. Clin Neurophysiol 2011; 122:171-175.
95. Deuschl G, Lohle E, Heinen F, Lucking C. Ear click in palatal tremor: its origin and treatment with botulinum toxin. Neurology 1991; 41:1677-1679.
96. Deuschl G, Wilms H. Palatal tremor: the clinical spectrum and physiology of a rhythmic movement disorder. Adv Neurol 2002; 89:115-130.
97. Deuschl G, Wilms H. Clinical spectrum and physiology of palatal tremor. Mov Disord 2002; 17 (Suppl 2):S63-S66. (Pubitemid 36040894)
98. Kumar N, Eggers SD, Milone M, Keegan BM. Acquired progressive ataxia and palatal tremor: importance of MRI evidence of hemosiderin deposition and vascular malformations. Parkinsonism Relat Disord 2011; 17:565-568.
99. Shaikh AG, Hong S, Liao K, et al. Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain 2010; 133:923-940.